Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH antagonist (Cetrotide) for ovulation induction in poor ovarian responders compared with previous ART cycles
IRCT2014100819464N1Phase 2Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- May 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2 trial of cetrorelix in poor ovarian response (POR) and female infertility, sponsored by Kerman University of Medical Sciences. Started May 2013; status: completed.
02
Drugs
cetrorelix
03
Conditions
poor ovarian response (POR)female infertility
Beyond the preview
Go deeper on IRCT2014100819464N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014100819464N1.